PharmaLedger is headed to our first European Blockchain Convention in person!
After numerous virtual editions, the upcoming European Blockchain Convention (EBC) will be held in Barcelona, Spain, on the 26th-28th of June 2022. Industry leaders and attendees will come together to discuss the current and future state of blockchain technology. Over 100 speakers will take part in various discussions, keynotes, workshops and fireside chats. Some highlighted topics of this next EBC edition will include crypto, DeFi, NFTs, and Web 3.
EBC became our dissemination partner during the first year of our PharmaLedger project in 2020, and this is our fourth time participating in their event. We are looking forward to meeting many familiar faces in person, and we are excited to discuss blockchain in healthcare and our evolving PharmaLedger project.
PharmaLedger Track Session: “PharmaLedger – A Digital Trust Ecosystem for Healthcare”
Date & Time: 27th of June | 16:30 (GMT+2)
Moderator: PharmaLedger’s Culture and Adoption Co-Lead Dr. Hirkirit Virdee (Novartis)
- PharmaLedger’s Requirement and Business Use Case Co-Lead Paolo Migliari (MSD)
- VP Quality, Trust & Safety James Gannon (PharmaLedger Association)
- PharmaLedger’s Architecture & Reference Implementation Co-Lead Marco Cuomo (Novartis)
- Blockchain Architect for Finished Goods Traceability and Clinical Supply Chain Use Cases Lukas Osterheider (Bayer)
This PharmaLedger Track Session will give an overview of our project and more background information about the next phase of the project, which is transitioning from “blockchain-enabled healthcare” to the building of our “Digital Trust Ecosystem (DTE).”
Join PharmaLedger at EBC in Barcelona
We couldn’t be more excited to be attending EBC in person this time around. If you would like to join us in Barcelona, we are offering a 25% discount code to the PharmaLedger Community. Make sure to add the special promo code below when buying your EBC ticket. We can’t wait to meet you!
25% Discount Special Promo Code: EBC-25PHARLED
Sign up for our newsletter below if you’d like to receive monthly updates about the PharmaLedger project.